Highland Financial Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Highland Financial Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,372	Closed	-$217K	–	45
2023 Q2	$217K	Sell	6,372 -312	-5%	-$9.81K	0.11%	42
2023 Q1	$201K	Sell	6,684 -4,820	-42%	-$149K	0.11%	44
2022 Q4	$325K	Buy	11,504 +785	+7%	+$24.9K	0.19%	39
2022 Q3	$352K	Buy	10,719 +1,380	+15%	+$50.7K	0.24%	45
2022 Q2	$294K	Buy	+9,339	New	+$327K	0.2%	44

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Highland Financial Advisors's ARKG Position: Q3 2023 in Review

Highland Financial Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 6,372 shares — an estimated $217K sold.

Highland Financial Advisors first reported a position in ARKG in Q2 2022 and held it in 5 quarters. The position peaked at $352K in Q3 2022. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Highland Financial Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
Highland Financial Advisors sold 6,372 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $217K.
Highland Financial Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2022 and held it in 5 quarters.
Highland Financial Advisors's ARK Genomic Revolution ETF position peaked at $352K in Q3 2022.
286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Highland Financial Advisors's 13F filing for Q3 2023, filed 25 Oct 2023.